T12_2_15_1

2011 National Healthcare Quality and Disparities Reports

The National Healthcare Quality Report (NHQR) is a comprehensive national overview of quality of health care in the United States. It is organized around four dimensions of quality of care: effectiveness, patient safety, timeliness, and patient centeredness.

Table 12_2_15.1
Adverse events in patients receiving knee joint replacement, United States, 2002-2007 and 2009^a
		2009			2007		2006		2005		2004		2003		2002
Population group		Sample size	Percent	SE	Percent	SE	Percent	SE	Percent	SE	Percent	SE	Percent	SE	Percent	SE
Total		1,460	3.3	0.5	2.1	0.6	4.0	0.8	3.2	0.7	5.0	0.9	5.7	1.0	8.1	0.9
Age	Under 65	614	2.4	0.6	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU
	65-74	501	3.6	0.8	DSU	DSU	4.4	1.1	DSU	DSU	4.5	1.2	5.5	1.4	7.4	1.2
	75-84	309	4.5	1.2	DSU	DSU	DSU	DSU	DSU	DSU	5.2	1.5	DSU	DSU	10.1	1.6
	85 and over	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU
Gender	Male	527	3.0	0.8	DSU	DSU	DSU	DSU	DSU	DSU	4.9	1.4	10.6	2.3	8.3	1.6
Gender	Female	933	3.4	0.6	DSU	DSU	4.0	1.0	3.3	0.8	5.0	1.1	3.1	0.9	8.0	1.1
Race	White	1,269	3.5	0.5	2.1	0.6	3.9	0.8	3.2	0.7	5.0	0.9	5.7	1.1	7.7	0.9
	Black	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU
	Other	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU
Diabetes	Yes	368	5.4	1.2	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	9.4	2.3
Diabetes	No	1,092	2.6	0.5	2.5	0.7	3.9	0.9	3.1	0.7	5.0	1.0	5.1	1.1	7.8	1.0
Obesity	Yes	453	4.0	0.9	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	13.8	3.1
Obesity	No	1,007	3.0	0.5	2.4	0.7	3.9	0.8	3.5	0.8	5.2	1.0	5.2	1.1	7.2	0.9
Cerebrovascular disease	Yes	DSU	DSU	DSU	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
Cerebrovascular disease	No	1,355	3.1	0.5	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
CHF/pulmonary edema	Yes	DSU	DSU	DSU	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
CHF/pulmonary edema	No	1,395	3.0	0.5	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
COPD	Yes	DSU	DSU	DSU	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
COPD	No	1,321	3.1	0.5	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
Smoking	Yes	DSU	DSU	DSU	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
Smoking	No	1,273	3.1	0.5	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
Corticosteroids	Yes	DSU	DSU	DSU	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
Corticosteroids	No	1,431	3.2	0.5	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
Coronary artery disease	Yes	261	4.6	1.3	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
Coronary artery disease	No	1,199	3.0	0.5	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
Renal disease	Yes	DSU	DSU	DSU	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
Renal disease	No	1,385	3.2	0.5	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA	DNA
Steroids	Yes	DNA	DNA	DNA	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU	DSU
Steroids	No	DNA	DNA	DNA	2.2	0.6	4.1	0.8	3.2	0.7	5.1	0.9	5.9	1.0	8.1	0.9

^a. Data were not collected in 2008. The 2002-2007 data include Medicare beneficiaries discharged from January to December and the 2009 data include Medicare beneficiaries discharged from January to September.

DNA - Data have not been analyzed.

DSU - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.

Page last reviewed October 2014

Internet Citation: T12_2_15_1: 2011 National Healthcare Quality and Disparities Reports. October 2014. Agency for Healthcare Research and Quality, Rockville, MD. http://archive.ahrq.gov/research/findings/nhqrdr/nhqrdr11/12_patientsafety/T12_2_15_1.html